Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
HIV/AIDS
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood. The primary objectives of this study are: To identify infectious and non-infectious complications of HIV di...

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood. The primary objectives of this study are: To identify infectious and non-infectious complications of HIV disease and toxicities resulting from long-term ART, including disease progression, immune suppression, viral resistance, end-organ disease, and mortality. To define the impact of HIV infection and ART on the long-term clinical outcomes of young adults with perinatal HIV. To define the impact of perinatal HIV infection and ART on long-term mental and behavioral health outcomes.

Tracking Information

NCT #
NCT03279185
Collaborators
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Institute on Drug Abuse (NIDA)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • NIH Office of AIDS Research (OAR)
  • National Institute of Mental Health (NIMH)
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • National Institute on Deafness and Other Communication Disorders (NIDCD)
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Investigators
Principal Investigator: George R Seage, ScD, MPH Harvard School of Public Health Study Chair: Katherine Tassiopoulos, DSc, MPH Harvard School of Public Health Study Chair: Russell B Van Dyke, MD Tulane University School of Medicine